The Prevalence of Pain in Patients Attending Sarcoma Outpatient Clinics

الملخص EN

The prevalence of pain in patients with sarcoma is not well documented.

We investigated this in outpatients at a tertiary cancer referral centre, assessing the adequacy of pain control and for risk factors leading to higher prevalence and severity of pain.

149 patients were surveyed.

Patients with pain within the previous 7 days completed pain assessment tools (BPI, S-LANSS, PMI).

53% of patients had pain within the previous 7 days, and 25% had significant pain.

Of those with pain, 63% was inadequately controlled and neuropathic pain was identified in 36%.

Age, gender, tumour type, and the type of cancer treatment were not significant predictors of the prevalence or severity of the pain.

Based on our results, patients with sarcoma should be actively screened for pain and have regular reviews of their analgesic requirements.